Resistance in Vancomycin-Resistant Enterococci
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Serious infections owing to vancomycin-resistant enterococci have historically proven to be difficult clinical cases, requiring combination therapy and management of treatment-related toxicity. Despite the introduction of new antibiotics with activity against vancomycin-resistant enterococci to the therapeutic armamentarium, significant challenges remain. An understanding of the factors driving the emergence of resistance in vancomycin-resistant enterococci, the dynamics of gastrointestinal colonization and microbiota-mediated colonization resistance, and the mechanisms of resistance to the currently available therapeutics will permit clinicians to be better prepared to tackle these challenging hospital-associated pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“The microbiota of the human GI tract consists of over 100 cultivable species and many more that rely on symbiotic relationships with members of the larger microbial community or human host for growth (67).”
BackgroundDesai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., Pudlo, N. A., Kitamoto, S., Terrapon, N., Muller, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.043 · Cited by 2,805
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Self-citationSymbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028 · cited 1×
“Vancomycin binds to the terminal two D-alanine residues of the pentapeptide moiety of peptidoglycan, inhibiting the transglycosylation and transpeptidation reactions and leading to an arrest of cell wall synthesis (43).”
BackgroundTaur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y. J., Dubin, K. A., Socci, N. D., Viale, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis580 · Cited by 1,020
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., Viale, A., Socci, N. D., van den Brink, M. R. M., Kamboj, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43918 · Cited by 943 · cited 1×
“In the clinical setting, loss of a diverse intestinal flora after antibiotic administration with subsequent domination by VRE was a precipitating event that predicted subsequent bacteremia in hospitalized patients with neutropenia (76, 77).”
BackgroundMechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
Self-citationVancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G. (2008) · Nature · doi:10.1038/nature07250 · Cited by 631 · cited 2×
“In a murine GI colonization model, depletion of Gram-negative commensals via the administration of broad-spectrum antibiotics promoted VRE colonization, a phenotype that could be rescued through exogenous administration of LPS (79).”
BackgroundSchleifer, K. H., & Kilpper-Balz, R. (1984) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-34-1-31 · Cited by 603 · cited 1×
“Early experience in treating infective endocarditis with penicillin monotherapy revealed that a subset of streptococci (now known to be enterococci since the genus Enterococcus would not be formally established until 1984 (4)) displayed an inherent tolerance to the action of this drug (5).”
BackgroundUbeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N. C., Equinda, M., Lipuma, L., Ling, L., Gobourne, A., No, D., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01197-12 · Cited by 466 · cited 2×
“Moreover, patients who developed VRE colonization after allogeneic-hematopoietic stem cell transplantation were more likely to have reduced levels of anaerobic Barnesiella in the pre-transplant microbiota, suggesting a role for this genus in preventing VRE domination in the clinical setting, although the specific mech…”
BackgroundGenetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377 · cited 4×
“Three major two component regulatory systems have been implicated in enterococcal DAP resistance to date, including LiaFSR, YycFG, and YxdJK (86, 87, 98).”
BackgroundSelf-citationTran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192 · cited 1×
“faecalis, these changes lead to redistribution of membrane phospholipid microdomains away from the division septum, potentially as a “diversion” tactic to protect the sensitive biosynthetic machinery located at the septum where cell division occurs (97).”
BackgroundSelf-citationGavaldà, J., Torres, C., Tenorio, C., López, P., Zaragoza, M., Capdevila, J. A., Almirante, B., Ruiz, F., Borrell, N., Gomis, X., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.639 · Cited by 134 · cited 1×
“Subsequent studies confirmed this synergism with the combination of ampicillin and ceftriaxone in vitro, and in a rabbit model of infective endocarditis (38, 39).”
Munita, J. M., Panesso, D., Diaz, L., Tran, T. T., Reyes, J., Wanger, A., Murray, B. E., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-12 · Cited by 118 · cited 1×
“, from 1 to 4 μg/mL, previously in the “susceptible” category) (103).”
BackgroundSelf-citationMunita, J. M., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., & Arias, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00021-13 · Cited by 70 · cited 2×
“Indeed, clinical failures of DAP have been associated with this scenario (101), and isolates with DAP MICs in the 3 to 4 μg/mL range are associated with mutations in the LiaFSR system (104).”
BackgroundSelf-citationGenes homologous to glycopeptide resistance van A are widespread in soil microbial communities
Guardabassi, L., & Agersø, Y. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00270.x · Cited by 47 · cited 1×
“Gene clusters coding for vancomycin resistance are common in nature, and the source of the van genes identified in current enterococcal isolates is likely a soil bacteria of the genus Paenibacillus (50).”
Background
Cited by
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Self-citation
Metadata
- Authors
- Miller, W. R., Murray, B. E., Rice, L. B., & Arias, C. A.
- Venue
- Infectious Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 34
- Issue
- 4
- Pages
- 751-771
- ISSN
- 0891-5520 (ISSN-L)
- OpenAlex
- W3097464624
- Cited by
- 173
- References
- 18
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.